EP2519227A4 - Gestion de la myoclonie par le glutathion réduit liposomal oral - Google Patents

Gestion de la myoclonie par le glutathion réduit liposomal oral

Info

Publication number
EP2519227A4
EP2519227A4 EP10841709.8A EP10841709A EP2519227A4 EP 2519227 A4 EP2519227 A4 EP 2519227A4 EP 10841709 A EP10841709 A EP 10841709A EP 2519227 A4 EP2519227 A4 EP 2519227A4
Authority
EP
European Patent Office
Prior art keywords
myoclonus
management
reduced glutathione
liposomal reduced
oral liposomal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10841709.8A
Other languages
German (de)
English (en)
Other versions
EP2519227A2 (fr
Inventor
F Timothy Guilford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/649,698 external-priority patent/US20100166846A1/en
Application filed by Individual filed Critical Individual
Publication of EP2519227A2 publication Critical patent/EP2519227A2/fr
Publication of EP2519227A4 publication Critical patent/EP2519227A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
EP10841709.8A 2009-12-30 2010-12-30 Gestion de la myoclonie par le glutathion réduit liposomal oral Withdrawn EP2519227A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29090309P 2009-12-30 2009-12-30
US12/649,698 US20100166846A1 (en) 2008-12-31 2009-12-30 Management of myoclonus with oral liposomal reduced glutathione
PCT/US2010/062468 WO2011082283A2 (fr) 2009-12-30 2010-12-30 Gestion de la myoclonie par le glutathion réduit liposomal oral

Publications (2)

Publication Number Publication Date
EP2519227A2 EP2519227A2 (fr) 2012-11-07
EP2519227A4 true EP2519227A4 (fr) 2014-08-06

Family

ID=44227152

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10841709.8A Withdrawn EP2519227A4 (fr) 2009-12-30 2010-12-30 Gestion de la myoclonie par le glutathion réduit liposomal oral

Country Status (2)

Country Link
EP (1) EP2519227A4 (fr)
WO (1) WO2011082283A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060120A2 (fr) * 2004-11-07 2006-06-08 Guilford F Timothy Formulation liposomale pour administration par voie orale de glutathione (reduit)
WO2006105155A2 (fr) * 2005-03-29 2006-10-05 Guilford Timothy F Administration de glutathion (reduit) par intraveineuse ou encapsule dans des liposomes pour le traitement des effets du tnf-$g(a) et des symptomes viraux pseudogrippaux
WO2007030492A2 (fr) * 2005-09-06 2007-03-15 Guilford F Timothy Methode de traitement d'une infection par le virus hhv-6 et d'attenuation des symptomes lies au virus, par encapsulation liposomiale et administration de glutathion reduit

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060120A2 (fr) * 2004-11-07 2006-06-08 Guilford F Timothy Formulation liposomale pour administration par voie orale de glutathione (reduit)
WO2006105155A2 (fr) * 2005-03-29 2006-10-05 Guilford Timothy F Administration de glutathion (reduit) par intraveineuse ou encapsule dans des liposomes pour le traitement des effets du tnf-$g(a) et des symptomes viraux pseudogrippaux
WO2007030492A2 (fr) * 2005-09-06 2007-03-15 Guilford F Timothy Methode de traitement d'une infection par le virus hhv-6 et d'attenuation des symptomes lies au virus, par encapsulation liposomiale et administration de glutathion reduit

Also Published As

Publication number Publication date
EP2519227A2 (fr) 2012-11-07
WO2011082283A2 (fr) 2011-07-07
WO2011082283A9 (fr) 2011-11-10

Similar Documents

Publication Publication Date Title
HK1254977A1 (zh) 索非布韋(sofosbuvir)的結晶形式
SG10201500763XA (en) Structured silicon battery anodes
ZA201303436B (en) Oral engagement assemblies
ZA201206131B (en) Fluorometric sensor
EP2475029A4 (fr) Batterie
EP2438246A4 (fr) Aspects de construction
EP2633062A4 (fr) Dérivés de biotine
EP2579354A4 (fr) Batterie fine
EP2392042A4 (fr) Structure de languettes pour pile
GB201216277D0 (en) Oral supplement
EP2562179A4 (fr) Glutathion oxydé cristallin et son procédé de fabrication
EP2365821A4 (fr) Forme cristalline de la linaclotide
EP2441107A4 (fr) Batterie mince
EP2439067A4 (fr) Stratifié de caoutchouc-résine
EP2408055A4 (fr) Batterie à air
GB2469543B (en) Construction of geometrical shapes
EP2478010A4 (fr) Peptide partiel de lacritine
TWM388993U (en) Structure of screwdriver head
EP2519227A4 (fr) Gestion de la myoclonie par le glutathion réduit liposomal oral
TWM390840U (en) Structure of opening wrench
TWM390844U (en) Structure improvement of a screwdriver
TWM388994U (en) Improved structure of screwdriver
TWM372028U (en) Structure of wire-peeling pliers
TWM402371U (en) Discharge head structure of wall-embedding type
TWM372743U (en) Improved structure of Kendama

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120727

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

R17D Deferred search report published (corrected)

Effective date: 20111110

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/08 20060101ALI20140702BHEP

Ipc: A61K 31/40 20060101ALI20140702BHEP

Ipc: A61P 25/00 20060101ALI20140702BHEP

Ipc: A61K 9/127 20060101AFI20140702BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150205